Suchergebnisse - "Galluzzo, Marco"

PubPharm (91)

51

Skin immunity and its dysregulation in psoriasis

enthalten in: Cell cycle (Georgetown, Tex.) | 2019

von Lanna, C. | Mancini, M. | Gaziano, R. | +10

52

Secukinumab shows high efficacy irrespective of HLA-Cw6 status in patients with moderate-to-severe plaque-type psoriasis : results from extension phase of the SUPREME study

enthalten in: The British journal of dermatology | 2019

von Papini, M. | Cusano, F. | Romanelli, M. | +58

53

Successful treatment of psoriatic crumbly nails with ustekinumab

enthalten in: Dermatologic therapy | 2019

von Galluzzo, M. | D'Adamio, S. | Chimenti, M. | +3

54

Biologic therapy for acrodermatitis continua of Hallopeau : Successful treatment with secukinumab and review of the literature

enthalten in: Dermatologic therapy | 2019

von Galluzzo, M. | D'Adamio, S. | Teoli, M. | +2

55

Psoriasis in pregnancy : case series and literature review of data concerning exposure during pregnancy to ustekinumab

enthalten in: The Journal of dermatological treatment | 2019

von Galluzzo, M. | D'Adamio, S. | Bianchi, L. | +1

CommentIn: J Dermatolog Treat. 2019 May;30(3):309. - PMID 30078336

56

Efficacy of sinecatechins 10% as proactive sequential therapy of external genital warts after laser CO2 ablative therapy : The PACT study (post-ablation immunomodulator treatment of condylomata with sinecatechins): a randomized, masked outcome assessment, multicenter trial

enthalten in: International journal of STD & AIDS | 2019

von Puviani, M. | Galluzzo, M. | Talamonti, M. | +6

57

Evaluation of alexithymia in patients affected by rheumatoid arthritis and psoriatic arthritis : A cross-sectional study

enthalten in: Medicine | 2019

von Chimenti, M. | Fonti, G. | Conigliaro, P. | +8

58

Treating a Multidrug-Resistant Psoriatic HLA-C*18:01 Allele Carrier with Combination Ustekinumab Apremilast Therapy

enthalten in: Molecular diagnosis & therapy | 2018

von Galluzzo, M. | D'Adamio, S. | Campione, E. | +2

59

Secukinumab shows high efficacy irrespective of HLA-Cw6 status in patients with moderate-to-severe plaque-type psoriasis : SUPREME study

enthalten in: The British journal of dermatology | 2018

von Costanzo, A. | Bianchi, L. | Flori, M. | +53

60

Treating a Multidrug-Resistant Psoriatic HLA-C*18:01 Allele Carrier with Combination Ustekinumab Apremilast Therapy

enthalten in: Molecular diagnosis & therapy | 2018

von Galluzzo, M. | D’Adamio, S. | Campione, E. | +2